Who owns Idenix Pharmaceuticals?

Key details on Idenix Pharmaceuticals (Ticker: IDIX)

Who owns Idenix Pharmaceuticals?

Is IDIX a good stock to own? Find out who bought Idenix Pharmaceuticals, who sold Idenix Pharmaceuticals (IDIX) stock, and who holds a large position in Idenix Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baupost 53.33M $1.27B June 30, 2014
Vanguard 7.18M $173.15M June 30, 2014
BlackRock Fund Advisors 4.38M $105.51M June 30, 2014
BlackRock Institutional Trust Company, N.A. 3.66M $88.20M June 30, 2014
Brookside Capital Management, LLC* 3.36M $81.09M June 30, 2014
MPM Asset Management 3.32M $34.15M June 30, 2012
AQR Capital Management 3.03M $72.92M June 30, 2014
Camber Capital Management 2.75M $9.93M June 30, 2013
Cormorant Asset Management 2.50M $15.07M March 31, 2014
STATE STREET CORPORATION 2.47M $59.49M June 30, 2014
FRED ALGER MANAGEMENT 2.29M $8.11M March 31, 2013
Sarissa Capital Management 2.00M $48.20M June 30, 2014
Capital World Investors^ 1.92M $11.48M Dec. 31, 2013
FMR 1.81M $9.45M Sept. 30, 2013
Westfield Capital Management Company 1.75M $9.07M Sept. 30, 2013
Ameriprise Financial 1.71M $17.65M June 30, 2012
MORGAN STANLEY 1.66M $39.89M June 30, 2014
Adage Capital Partners GP 1.53M $5.53M June 30, 2013
CITADEL ADVISORS 1.51M $5.47M June 30, 2013
Bridger Management 1.50M $9.04M March 31, 2014
Janus Capital Management 1.49M $7.77M Sept. 30, 2013
12 West Capital Management 1.43M $34.50M June 30, 2014
T. Rowe Price Associates 1.40M $33.85M June 30, 2014
BB Biotech AG 1.40M $13.71M March 31, 2012
Highline Capital Management 1.37M $6.23M Sept. 30, 2012
NORTHERN TRUST 1.36M $8.19M March 31, 2014
Visium Asset Management 1.31M $6.81M Sept. 30, 2013
Arrowgrass Capital Partners 1.30M $6.75M Sept. 30, 2013

Who sold Idenix Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
OrbiMed Advisors June 30, 2011 2.72M $13.58M
Columbia Wanger Asset Management June 30, 2011 2.67M $13.37M
Wellington Management Company June 30, 2011 1.51M $7.53M
J P MORGAN CHASE & CO Dec. 31, 2010 1.83M $8.41M